- Home
- MHH vs NRXP Comparison
MHH vs NRXP Comparison
Compare MHH & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHH | NRXP |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.5M | 70.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MHH | NRXP |
|---|---|---|
| Price | $7.40 | $2.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $30.67 |
| AVG Volume (30 Days) | 34.4K | ★ 583.2K |
| Earning Date | 02-18-2026 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $196,657,000.00 | $242,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.50 | $821.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.24 | N/A |
| 52 Week Low | $6.20 | $1.58 |
| 52 Week High | $15.74 | $6.01 |
Technical Indicators
Market Signals| Indicator | MHH | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 45.80 |
| Support Level | $6.44 | $2.33 |
| Resistance Level | $7.68 | $2.48 |
| Average True Range (ATR) | 0.43 | 0.18 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 68.32 | 26.35 |
Price Performance
Historical ComparisonAbout MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.